AULIN SHERRY

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
AULIN SHERRY's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
44.18
Quantity 53,851 -2.2%
Value US$3,703,918
Transaction date
Proposed sale
Price
41.21
Quantity 18,709
Value US$770,909
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-19 2025-09-19
PrS Proposed sale
55,081
131.84
US$2,389,093 		55,081 131.84 US$2,389,093
2024-12-19 2024-12-18
S Sale
76,108 -17.3%
184.49
US$127,242 		76,108 -17.3% 184.49 US$127,242
2024-12-19 2024-12-18
S Sale
53,851 -2.2%
44.18
US$3,703,918 		53,851 -2.2% 44.18 US$3,703,918
2024-12-18 2024-12-18
PrS Proposed sale
18,709
41.21
US$770,909 		18,709 41.21 US$770,909
2022-09-07 2022-09-02
S Sale
15,355 -100.0%
39.57
US$607,597 		15,355 -100.0% 39.57 US$607,597